Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PETERSBURG – The world’s second-largest pharmaceutical company is taking ownership of AMPAC Fine Chemicals’ Petersburg ...

The Bill and Melinda Gates Foundation is a charitable organization that has spent tens of billions of dollars fighting global ...

As a result, Novo Nordisk, the Danish drugmaker that’s ... as regulators in the U.S. and Europe investigated whether Novo Holdings’ ownership would be anticompetitive. In the U.S., some ...

“Today represents an important step in our transition to private ownership under Novo Holdings ... Scholer LLP and Davis Polk & Wardwell LLP served as legal advisors to Novo Nordisk. About Novo ...

Novo Nordisk's CargiSema Phase III trial showed significant weight loss but failed reach ambitious targets set by management.

Catalent to Strengthen its Leading Position as a Global Service Provider for the Pharma and Biotech Industry under Private Ownership Catalent ... following the completion of the transaction, Novo ...

PETERSBURG – The world’s second-largest pharmaceutical company is taking ownership of AMPAC Fine Chemicals’ Petersburg location. Denmark-based Novo Nordisk told The Progress-Index in an ...

Biocon and Zentiva receive EU approval for generic versions of Victoza (diabetes) and Saxenda (weight management). This marks ...